GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (LTS:0A9W) » Definitions » Net Interest Income (for Banks)

Organon (LTS:0A9W) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Organon Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Organon (LTS:0A9W) Business Description

Industry
Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.